Evidence map›Paper›PMID 25060069›Full record

ArticleJournal of the American Chemical Society2014

Inhibition and mechanism of HDAC8 revisited.

Kai Chen, Xiaoxiao Zhang, Yun-Dong Wu, Olaf Wiest

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Critical review of non-histone human substrates of metal-dependent lysine deacetylases.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2020
    Review
  9. Review
  10. Article
  11. Review
  12. Optimal Substrate-Trapping Mutants to Discover Substrates of HDAC1.Chembiochem : a European journal of chemical biology · 2019
    Article
  13. Article
  14. Computer-Aided Drug Design in Epigenetics.Frontiers in chemistry · 2018
    Review
  15. Article
  16. Article
  17. Article
  18. Development of a Potent and Selective HDAC8 Inhibitor.ACS medicinal chemistry letters · 2016
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Kai ChenLab of Computational Chemistry and Drug Design, Laboratory of Chemical Genomics, Peking University Shenzhen Graduate School , Shenzhen 518055, China.
Xiaoxiao Zhang
Yun-Dong Wu
Olaf Wiest
Peking University · CNUniversity of Notre Dame · US

Funding

Multiple Myeloma and Cancer Therapies via Largazole AnalogsR01CA152314 · NCI · COLORADO STATE UNIVERSITY · PI WILLIAMS, ROBERT MICHAEL · 2010 to 2014
$1.5M
NCI NIH HHS R01 CA152314
6 · The paper itself

Abstract

Histone deacetylases (HDACs) have found intense interest as drug targets for a variety of diseases, but there is disagreement about basic aspects of the inhibition and mechanism of HDACs. QM/MM calculations of HDAC8 including a large QM region provide a model that is consistent with the available crystal structures and structure-activity relationships of different HDAC inhibitors. The calculations support a spontaneous proton transfer from a hydroxamic acid to an active site histidine upon binding to the zinc. The role of the H142/D176 catalytic dyad as the general base of the reaction is elucidated. The reasons for the disagreements between previous proposals are discussed. The results provide detailed insights into the unique mechanism of HDACs, including the role of the two catalytic dyads and function of the potassium near the active site. They also have important implications for the design of novel inhibitors for a number of HDACs such as the class IIa HDACs.

Indexed as

Histone Deacetylase InhibitorsHistone DeacetylasesHumansModels, MolecularMolecular StructureQuantum TheoryRepressor ProteinsStructure-Activity RelationshipHDAC8 protein, humanHistone Deacetylase InhibitorsHistone DeacetylasesRepressor Proteins

Identifiers

PMID25060069
PMCPMC4140456
OpenAlexW2325550803

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.